Commentary & Perspectives

2025 San Antonio Breast Cancer Symposium Recap

Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

Share

At the 2025 San Antonio Breast Cancer Symposium, Dr. Harold Burstein highlights significant advancements in breast cancer research, focusing on new treatment protocols, novel therapeutics, and promising clinical trial results. The symposium gathered experts to discuss groundbreaking findings that could improve patient outcomes and influence future breast cancer management. The discussions emphasized the integration of personalized medicine strategies and the importance of ongoing research in this evolving field.

Original Source(s)

2025 San Antonio Breast Cancer Symposium Recap

  • March 17, 2026

Related Content

SABCS 2025 Highlights: Patient Perspective

Lindsay Northrop, breast cancer survivor and patient advocate at Dana-Farber, talks with Harold Burstein, MD, PhD, about how recent advances in breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium will impact patient care.

  • March 17, 2026

SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer

Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH, discuss research in hormone replacement therapy for breast cancer that was presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

SABCS Highlights: Advances in Oral SERD's for Breast Cancer

Harold Burstein, MD, PhD, and Rinath M. Jeselsohn, MD, discuss the lidERA, evERA, and EMBER-3 trials researching oral selective estrogen receptor degraders (SERDs).

  • March 17, 2026